FDA Says “No” to CBD Foods and Dietary Supplements January 26, 2023 AggregatedNews Federal, Hemp Policy & Legal 0 Comments By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA convened a working group to study how the agency would… Read More→
FDA finalizes guidance on cannabis clinical research January 26, 2023 AggregatedNews Federal, Hemp Policy & Legal 0 Comments The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without running afoul of federal law. When Congress passed the Agriculture Improvement… Read More→
Human Trial Showing CBD Safe A Boost For Industry In Battles With Regulators March 26, 2021 Peter McCusker Hemp Business Executive, Hemp Industry News 0 Comments RESULTS from a major US trial over 800 people over the past seven months found CBD use has zero impact on the liver. In March, last year the US Food and Drug Administration (FDA) requested specific data on liver toxicity… Read More→
The Emerging Hemp Industry – Government Regulation Can Help Businesses Grow October 7, 2020 Robert Roche Hemp Policy & Legal 0 Comments by Robert Roche Hemp cultivation and processing could be a boon for the struggling farmers and small businesses. Economists estimate consumer demand for the (non-psychoactive) hemp-derived CBD market could reach $22 billion by 2022. While COVID-19 has triggered record high… Read More→
Is synthetic CBD a controlled substance under the Controlled Substances Act? April 15, 2020 Arthur Hoffmann Hemp Policy & Legal, Policy & Legal 0 Comments By Arthur Hoffmann and Chris Gismondi Cannabidiol (CBD) is a compound found in the plant Cannabis sativa L. and is thought to have therapeutic properties. However, CBD derived from marijuana is an illegal controlled substance under the Controlled Substances Act,… Read More→